Information Journal Paper
APA:
Copy. (2020). Specific targeting of HER2-positive human breast carcinoma SK-BR-3 cells by amygdaline-ZHER2 affibody conjugate. MOLECULAR BIOLOGY REPORTS, 47(9), 7139-7151. SID. https://sid.ir/paper/1126571/en
Vancouver:
Copy. Specific targeting of HER2-positive human breast carcinoma SK-BR-3 cells by amygdaline-ZHER2 affibody conjugate. MOLECULAR BIOLOGY REPORTS[Internet]. 2020;47(9):7139-7151. Available from: https://sid.ir/paper/1126571/en
IEEE:
Copy, “Specific targeting of HER2-positive human breast carcinoma SK-BR-3 cells by amygdaline-ZHER2 affibody conjugate,” MOLECULAR BIOLOGY REPORTS, vol. 47, no. 9, pp. 7139–7151, 2020, [Online]. Available: https://sid.ir/paper/1126571/en